Your supply chain must evolve.
Already, supply chain leaders in the life sciences industry are pressured to make their supply chain better, faster, and more flexible. Once driven by the need for cost-savings, those same pressures are now driven as requirements for the safety and efficacy of next-generation treatments.
Cell and Gene Therapy Supply Chain Consulting
We partner with our clients to create the critical capabilities for this new era of supply chain management, including next-generation network design and capacity planning, end-to-end visibility, real-time tracking and reporting, and accelerated quality control.
We partner with supply chain leadership to create and execute data-driven, scalable strategies designed for your business’s specific patient populations and treatments.
- Commercialization Strategy and Planning
- Partner Engagement Strategy, Integration, and Execution
- Technology Roadmap for Commercialization
Leveraging deep industry experience with industry-recognized functional expertise, we develop supply chain solutions designed to accommodate the complex scientific and logistical implications of targeted cell and gene therapies.
- Supply Chain Network Design and Diagnostics
- Chain of Identity Risk Assessment and Mitigation Planning
- Capacity Planning Strategy
- Commercial Launch Management
- Scenario-Based Planning Model
We create and implement innovative technology solutions, customized to handle the unique production, scheduling, and treatment requirements of personalized medicine therapeutic models.
- Clarkston’s Cell Therapy Orchestration Platform
- Provider/Patient Collaboration Platforms
- Patient Scheduling Portal
What Our Clients Say
Group Chief Executive Officer
They don’t arrive with solutions looking for problems that fit them. Clarkston takes the time to understand our unique issues. They facilitate solutions vs. dictating solutions.